Ovarian cancer developments
23 Jun 2011
Ovarian cancer developments
Olaparib maintenance therapy for ovarian cancer and updates from ICON7
Suggested benefit of bevacizumab for newly diagnosed ovarian cancer patients at high risk of recurrence
ASCO 2011 highlights
Antiviral drugs as a radiosensitizer in HPV related tumours
Reducing global cancer mortality
The Cancer Genome Atlas (TCGA)
Ovarian cancer patients with BRCA mutations show improved survival
Chronic stress of cancer causes accelerated telomere shortening
Effects of stress on cancer progression
Ovarian cancer patients with BRCA mutations show improved survival
Recurrent ovarian cancer treatment practices